Record Information |
---|
Version | 2.0 |
---|
Creation Date | 2009-11-13 22:52:25 UTC |
---|
Update Date | 2014-12-24 20:26:13 UTC |
---|
Accession Number | T3D3607 |
---|
Identification |
---|
Common Name | Ochratoxin C |
---|
Class | Small Molecule |
---|
Description | Ochratoxin C is a metabolite of Aspergillus ochraceus
Ochratoxin C belongs to the family of Ochratoxins and related substances. These are compounds containing the ochratoxin skeleton, which is structurally characterized by the presence of a 3-phenylpropanoic acid N-linked to a 8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1H-2-benzopyran-7-carboxamide moiety[1]. (Reference: [1] http://www.inchem.org/documents/ehc/ehc/ehc105.htm). |
---|
Compound Type | - Amide
- Amine
- Ester
- Ether
- Food Toxin
- Fungal Toxin
- Metabolite
- Mycotoxin
- Natural Compound
- Organic Compound
- Organochloride
|
---|
Chemical Structure | |
---|
Synonyms | Synonym | Ochratoxin a ethyl ester |
|
---|
Chemical Formula | C22H22ClNO6 |
---|
Average Molecular Mass | 431.866 g/mol |
---|
Monoisotopic Mass | 431.114 g/mol |
---|
CAS Registry Number | 4865-85-4 |
---|
IUPAC Name | 5-chloro-N-(1-ethoxy-1-oxo-3-phenylpropan-2-yl)-8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1H-2-benzopyran-7-carboximidic acid |
---|
Traditional Name | 5-chloro-N-(1-ethoxy-1-oxo-3-phenylpropan-2-yl)-8-hydroxy-3-methyl-1-oxo-3,4-dihydro-2-benzopyran-7-carboximidic acid |
---|
SMILES | CCOC(=O)C(CC1=CC=CC=C1)N=C(O)C1=CC(Cl)=C2CC(C)OC(=O)C2=C1O |
---|
InChI Identifier | InChI=1/C22H22ClNO6/c1-3-29-21(27)17(10-13-7-5-4-6-8-13)24-20(26)15-11-16(23)14-9-12(2)30-22(28)18(14)19(15)25/h4-8,11-12,17,25H,3,9-10H2,1-2H3,(H,24,26) |
---|
InChI Key | InChIKey=BPZZWRPHVVDAPT-UHFFFAOYNA-N |
---|
Chemical Taxonomy |
---|
Description | belongs to the class of organic compounds known as glycosylamines. Glycosylamines are compounds consisting of an amine with a beta-N-glycosidic bond to a carbohydrate, thus forming a cyclic hemiaminal ether bond (alpha-amino ether). |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic oxygen compounds |
---|
Class | Organooxygen compounds |
---|
Sub Class | Carbohydrates and carbohydrate conjugates |
---|
Direct Parent | Glycosylamines |
---|
Alternative Parents | |
---|
Substituents | - Hexose monosaccharide
- N-glycosyl compound
- Alpha-amino acid
- Alpha-amino acid or derivatives
- Aralkylamine
- Monosaccharide
- Oxane
- Azole
- Heteroaromatic compound
- Isoxazole
- Vinylogous amide
- Amino acid or derivatives
- Amino acid
- Secondary alcohol
- Carboxylic acid derivative
- Carboxylic acid
- Oxacycle
- Azacycle
- Organoheterocyclic compound
- Monocarboxylic acid or derivatives
- Polyol
- Amine
- Organopnictogen compound
- Organic nitrogen compound
- Alcohol
- Carbonyl group
- Organic oxide
- Primary aliphatic amine
- Primary amine
- Organonitrogen compound
- Primary alcohol
- Hydrocarbon derivative
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Biological Properties |
---|
Status | Detected and Not Quantified |
---|
Origin | Exogenous |
---|
Cellular Locations | |
---|
Biofluid Locations | Not Available |
---|
Tissue Locations | Not Available |
---|
Pathways | Not Available |
---|
Applications | Not Available |
---|
Biological Roles | Not Available |
---|
Chemical Roles | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Appearance | White powder. |
---|
Experimental Properties | Property | Value |
---|
Melting Point | Not Available | Boiling Point | Not Available | Solubility | Not Available | LogP | Not Available |
|
---|
Predicted Properties | |
---|
Spectra |
---|
Spectra | Spectrum Type | Description | Splash Key | Deposition Date | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | splash10-0a4i-4019000000-d2a641a855118404e3bc | 2017-09-01 | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (2 TMS) - 70eV, Positive | splash10-03fu-9002260000-31b2f835982ccd442d9f | 2017-10-06 | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-001l-4212900000-efe849f14e9d887fdfa1 | 2016-06-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-000l-4397400000-e2938a4d4ece4b5ee369 | 2016-06-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0006-9210000000-46647db7246af80a6e10 | 2016-06-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-001i-2019500000-0e6b84dd14ef1152c403 | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-001j-6469400000-2b606454b44f5e5551c0 | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0006-9111000000-78fb701981189e5cacd6 | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-001i-0000900000-7ea3cfffa1f605d198df | 2021-09-22 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0f7o-4935800000-9f550c61aeec7cbd7cf4 | 2021-09-22 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0udi-4491000000-f6cb7f8400d2bc6255b5 | 2021-09-22 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-001i-0004900000-4bdf05cff8a50f221350 | 2021-09-22 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-0a5l-2593300000-926aecf8ff2fc365bdca | 2021-09-22 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0006-8950000000-00fa22804f8981975e62 | 2021-09-22 | View Spectrum |
|
---|
Toxicity Profile |
---|
Route of Exposure | Oral, dermal, inhalation, and parenteral (contaminated drugs). (3) |
---|
Mechanism of Toxicity | Ochratoxin A, a metabolite of Ochratoxin C, has been shown to be weakly mutagenic, possibly by induction of oxidative DNA damage. The nephrotoxin ochratoxin A (OTA) causes a reduction of glomerular filtration rate (GFR) and of para-aminohippuric acid (PAH) clearance. It is a nephrotoxin which blocks plasma membrane anion conductance in Madin-Darby canine kidney (MDCK) cells. (4) |
---|
Metabolism | It is concluded that ochratoxin C is readily converted to ochratoxin A after both oral and intravenous administration. (1) |
---|
Toxicity Values | Not Available |
---|
Lethal Dose | Not Available |
---|
Carcinogenicity (IARC Classification) | No indication of carcinogenicity to humans (not listed by IARC). |
---|
Uses/Sources | Human exposure occurs mainly through consumption of improperly stored food products, particularly contaminated grain and pork products, as well as coffee, wine grapes and dried grapes. (8) |
---|
Minimum Risk Level | Not Available |
---|
Health Effects | Ochratoxin exposure has been associated with acute tubular necrosis and Balkan endemic nephropathy. Ochratoxin A has been shown to be nephrotoxic; might delay sexual maturation. (5) |
---|
Symptoms | Might cause respiratory irritation. (5) |
---|
Treatment | Care is symptomatic and supportive. (5) |
---|
Normal Concentrations |
---|
| Not Available |
---|
Abnormal Concentrations |
---|
| Not Available |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
HMDB ID | HMDB29400 |
---|
PubChem Compound ID | 617474 |
---|
ChEMBL ID | Not Available |
---|
ChemSpider ID | 536626 |
---|
KEGG ID | Not Available |
---|
UniProt ID | Not Available |
---|
OMIM ID | |
---|
ChEBI ID | Not Available |
---|
BioCyc ID | Not Available |
---|
CTD ID | Not Available |
---|
Stitch ID | Not Available |
---|
PDB ID | Not Available |
---|
ACToR ID | Not Available |
---|
Wikipedia Link | Ochratoxin |
---|
References |
---|
Synthesis Reference | Not Available |
---|
MSDS | Not Available |
---|
General References | - Fuchs R, Hult K, Peraica M, Radic B, Plestina R: Conversion of ochratoxin C into ochratoxin A in vivo. Appl Environ Microbiol. 1984 Jul;48(1):41-2. [6476830 ]
- Hietanen E, Bartsch H, Bereziat JC, Castegnaro M, Michelon J: Characterization of the cytochrome P450 isozyme that metabolizes ochratoxin A, using metabolic inducers, inhibitors and antibodies. IARC Sci Publ. 1991;(115):297-304. [1820345 ]
- Peraica M, Domijan AM: Contamination of food with mycotoxins and human health. Arh Hig Rada Toksikol. 2001 Mar;52(1):23-35. [11370295 ]
- Gekle M, Silbernagl S: Mechanism of ochratoxin A-induced reduction of glomerular filtration rate in rats. J Pharmacol Exp Ther. 1993 Oct;267(1):316-21. [8229758 ]
- Grond S, Sablotzki A: Clinical pharmacology of tramadol. Clin Pharmacokinet. 2004;43(13):879-923. [15509185 ]
- Rumack BH POISINDEX(R) Information System Micromedex, Inc., Englewood, CO, 2010; CCIS Volume 143, edition expires Feb, 2010. Hall AH & Rumack BH (Eds): TOMES(R) Information System Micromedex, Inc., Englewood, CO, 2010; CCIS Volume 143, edition expires Feb, 2010.
- Yannai, Shmuel. (2004) Dictionary of food compounds with CD-ROM: Additives, flavors, and ingredients. Boca Raton: Chapman & Hall/CRC.
- Wikipedia. Ochratoxin A. Last Updated 26 February 2010. [Link]
- Wikipedia. Ochratoxin. Last Updated 29 March 2010. [Link]
|
---|
Gene Regulation |
---|
Up-Regulated Genes | Not Available |
---|
Down-Regulated Genes | Not Available |
---|